StonvexLoading…
StonvexStonvexStonvexCore line items from APVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $3.11M | $12.29M | $4.31M | $32.42M |
Operating Income | $-28.64M | $-21.40M | $-27.49M | $-40.96M |
Net Income | $8.03M | $-28.46M | $-17.75M | $-40.45M |
EPS (Diluted) | $1.57 | $-6.07 | Not available | Not available |
Total Assets | $34.22M | $56.60M | $53.55M | $53.41M |
Total Liabilities | $16.24M | $55.38M | $36.95M | $41.57M |
Cash & Equivalents | $22.64M | $45.04M | $39.98M | $12.45M |
Free Cash Flow OCF − CapEx | $-21.05M | $-22.39M | $-29.41M | $-42.54M |
Shares Outstanding | 6.47M | 4.90M | 4.41M | 3.23M |